Effects of zinc supplementation on diabetes mellitus: A systematic review and meta-analysis

Diabetology and Metabolic Syndrome

Volumn 4, Issue 1, 2012, Pages

  Jayawardena, R ^a,b   Ranasinghe, P ^a   Galappatthy, P ^a   Malkanthi, R L D K ^c   Constantine, G R ^a   Katulanda, P ^a  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c WAYAMBA UNIVERSITY OF SRI LANKA   (Sri Lanka)

Author keywords

Diabetes mellitus; Humans; Meta analysis; Zinc Supplementation

Indexed keywords

CHOLESTEROL; GLUCONATE ZINC; GLUCOSE; HEMOGLOBIN A1C; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; ZINC ACETATE; ZINC PHOSPHATE; ZINC SULFATE;

ABDOMINAL PAIN; CHOLESTEROL BLOOD LEVEL; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DIET SUPPLEMENTATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MEDLINE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 84862205290     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-4-13     Document Type: Review

References (64)

1. Wild S, Roglic G, Green A, Sicree R, King H, Global Prevalence of Diabetes. Diabetes Care 2004 27 1047 1053
2. WHO, Diabetes Fact Sheet http://www.who.int/mediacentre/factsheets/fs312/ en/index.html
3. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Wild S, Roglic G, Green A, Sicree R, King H, Diabetes Care http://www.diabetesatlas.com/content/economic-impacts-diabetes
4. Levin M, Pfeifer M, Uncomplicated Guide To Diabetes Complications American Diabetes Association, Alexandria, Virginia 3 2009
5. Type 2 diabetes: principles of pathogenesis and therapy. Stumvoll M, Goldstein BJ, van Haeften TW, Lancet 2005 365 1333 1346 10.1016/S0140-6736(05) 61032-X 15823385
6. The role of assembly in insulins biosynthesis. Dodson G, Steiner D, Curr Opin Struct Biol 1998 8 189 194 10.1016/S0959-440X(98)80037-7 9631292 (Pubitemid 28221050)
7. Zn(II) ions co-secreted with insulin suppress inherent amyloidogenic properties of monomeric insulin. Noormagi A, Gavrilova J, Smirnova J, Tougu V, Palumaa P, Biochem J 2010 430 511 518 10.1042/BJ20100627 20632994
8. Video image analysis of labile Zn in viable pancreatic islet cells using specific fluorescent probe for Zn. Zalewski P, Millard S, Forbes I, Kapaniris O, Slavotinek S, Betts W, Ward A, Lincoln S, Mahadevan I, J Histochem Cytochem 1994 42 877 884 10.1177/42.7.8014471 8014471 (Pubitemid 24198446)
9. The effect of zinc on insulin metabolism. Arquilla ER, Packer S, Tarmas W, Miyamoto S, Endocrinology 1978 103 1440 1449 10.1210/endo-103-4-1440 744156 (Pubitemid 9075629)
10. Zinc, insulin and diabetes. Chausmer AB, J Am Coll Nutr 1998 17 109 115 9550453
11. Use of antioxidants in the prevention and treatment of disease. Kelly F, J Int Fed Clin Chem 1998 10 21 23 10181011
12. Hypozincemia in diabetes mellitus. Garg VK, Gupta R, Goyal RK, J Assoc Physicians India 1994 42 720 721 7883669
13. Hyperzincuria of diabetes mellitus and possible genetical implications of this observation. Pidduck HG, Wren PJ, Evans DA, Diabetes 1970 19 240 247 5437978
14. Zinc deficiency, infectious disease and mortality in the developing world. Black RE, J Nutr 2003 133 1485S 1489S 12730449 (Pubitemid 36548732)
15. Dietary zinc supplementation attenuates hyperglycemia in db/db mice. Simon SF, Taylor CG, Exp Biol Med (Maywood) 2001 226 43 51
16. Lipid peroxidation in insulin-dependent diabetic patients with early retina degenerative lesions: Effects of an oral zinc supplementation. Faure P, Benhamou PY, Perard A, Halimi S, Roussel AM, Eur J Clin Nutr 1995 49 282 288 7796786
17. Effects of combination of zinc and vitamin A supplementation on serum fasting blood sugar, insulin, apoprotein B and apoprotein A-I in patients with type i diabetes. Shidfar F, Aghasi M, Vafa M, Heydari I, Hosseini S, Shidfar S, International Journal of Food Sciences and Nutrition 2010 61 182 191 10.3109/09637480903334171 20151940
18. Effect of zinc sulfate supplementation on lipid and glucose in type 2 diabetic patients. Afkhami-Ardekani M, Karimi M, Mohammadi SM, Nourani F, Pak J Nutr 2008 7 550 553 10.3923/pjn.2008.550.553 (Pubitemid 351689773)
19. Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of type 2 diabetics. Al-Maroof RA, Al-Sharbatti SS, Saudi Medical Journal 2006 27 344 350 16532095
20. Contradicted and initially stronger effects in highly cited clinical research. Ioannidis JP, JAMA 2005 294 218 228 10.1001/jama.294.2.218 16014596 (Pubitemid 41043792)
21. das Gracas Almeida M, de Araujo DM, dos Santos MM, de Lima VT, de Fatima Campos Pedrosa L: Effects of zinc supplementation in patients with type 1 diabetes. de Sena KC, Arrais RF, Biol Trace Elem Res 2005 105 1 9 10.1385/BTER:105:1-3:001 16034148
22. The increasing importance of systematic reviews in clinical dermatology research and publication. Freeman SR, Williams HC, Dellavalle RP, J Invest Dermatol 2006 126 2357 2360 10.1038/sj.jid.5700560 17041612 (Pubitemid 44582253)
23. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Moher D, Liberati A, Tetzlaff J, Altman DG, BMJ 2009 339 2535 10.1136/bmj.b2535 19622551
24. The combination of estimates from different experiments. Cochran WG, Biometrics 1954 10 101 129 10.2307/3001666
25. Quantifying heterogeneity in a meta-analysis. Higgins IP, Thompson SG, Stat Med 2002 21 1539 1558 10.1002/sim.1186 12111919 (Pubitemid 34746062)
26. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. Anderson RA, Roussel AM, Zouari N, Mahjoub S, Matheau JM, Kerkeni A, J Am Coll Nutr 2001 20 212 218 11444416 (Pubitemid 32606167)
27. Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation. Farvid MS, Homayouni F, Amiri Z, Adelmanesh F, Diabetes Research and Clinical Practice 2011 93 86 94 10.1016/j.diabres.2011.03. 016 21496936
28. Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes. Farvid MS, Jalali M, Siassi F, Hosseini M, Diabetes Care 2005 28 2458 2464 10.2337/diacare.28.10.2458 16186280 (Pubitemid 41384294)
29. The impact of vitamins and/or mineral supplementation on blood pressure in type 2 diabetes. Farvid MS, Jalali M, Siassi F, Saadat N, Hosseini M, J Am Coll Nutr 2004 23 272 279 15190052 (Pubitemid 38746116)
30. The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes. Farvid MS, Siassi F, Jalali M, Hosseini M, Saadat N, Diabetes Research and Clinical Practice 2004 65 21 28 10.1016/j.diabres.2003.11.009 15163474 (Pubitemid 38649045)
31. A 5-year follow-up of antioxidant supplementation in type 2 diabetic retinopathy. Garcia-Medina JJ, Pinazo-Duran MD, Garcia-Medina M, Zanon-Moreno V, Pons-Vazquez S, Eur J Ophthalmol 2011 21 637 643 10.5301/EJO.2010.6212 21218388
32. Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes. Gunasekara P, Hettiarachchi M, Liyanage C, Lekamwasam S, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011 4 53 60
33. Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin. Hussain SA, Khadim HM, Khalaf BH, Ismail SH, Hussein KI, Sahib AS, Saudi Med J 2006 27 1483 1488 17013468 (Pubitemid 351850025)
34. Effects of melatonin and zinc on lipid profile and renal function in type 2 diabetic patients poorly controlled with metformin. Kadhim HM, Ismail SH, Hussein KI, Bakir IH, Sahib AS, Khalaf BH, Hussain SA, J Pineal Res 2006 41 189 193 10.1111/j.1600-079X.2006.00353.x 16879326 (Pubitemid 44141755)
35. Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: A double blind, randomized, placebo-controlled, cross-over trial. Parham M, Amini M, Aminorroaya A, Heidarian E, Review of Diabetic Studies 2008 5 102 109 10.1900/RDS.2008.5.102 18795212
36. Effect of zinc replacement on lipids and lipoproteins in type 2-diabetic patients. Partida-Hernndez G, Arreola F, Fenton B, Cabeza M, Romn-Ramos R, Revilla-Monsalve MC, Biomed Pharmacother 2006 60 161 168 10.1016/j.biopha.2006. 02.004 16632297 (Pubitemid 43870417)
37. Short-term zinc supplementation in women with non-insulin-dependent diabetes mellitus: Effects on plasma 5'-nucleotidase activities, insulin- like growth factor I concentrations, and lipoprotein oxidation rates in vitro. Blostein-Fujii A, DiSilvestro RA, Frid D, Katz C, Malarkey W, Am J Clin Nutr 1997 66 639 642 9280186 (Pubitemid 27366790)
38. Effects of zinc supplementation in patients with type 1 diabetes. De Sena KCM, Arrais RF, Almeida MDG, De Arajo DM, Dos Santos MM, De Lima VT, Pedrosa LDFC, Biological Trace Element Research 2005 105 1 9 10.1385/BTER:105:1-3:001 16034148 (Pubitemid 41009042)
39. Oral zinc therapy in diabetic neuropathy. Gupta R, Garg VK, Mathur DK, Goyal RK, J Assoc Physicians India 1998 46 939 942 11229219 (Pubitemid 128524022)
40. Diabetic neuropathy and zinc therapy. Hayee MA, Mohammad QD, Haque A, Bangladesh Med Res Counc Bull 2005 31 62 67 16967811 (Pubitemid 44322348)
41. Effect Of Zinc Supplementation on Serum Glucose, Insulin, Glucagon, Glucose-6-Phosphatase and Mineral levels in Diabetics. Hegazi SM, Ahmed SS, Mekkawy AA, Mortagy MS, Abdelkadder M, Journal of Clinical Biochemistry and Nutrition 1992 12 209 215 10.3164/jcbn.12.209
42. Effect of zinc supplementation on serum homocysteine in type 2 diabetic patients with microalbuminuria. Heidarian E, Amini M, Parham M, Aminorroaya A, Review of Diabetic Studies 2009 6 38 44
43. Role of zinc supplementation in type II diabetes mellitus. Niewoehner CB, Allen JI, Boosalis M, Am J Med 1986 81 63 68 3464210 (Pubitemid 16044511)
44. The influence of zinc supplementation on glucose homeostasis in NIDDM. Raz I, Karsai D, Katz M, Diabetes Research 1989 11 73 79 2695282 (Pubitemid 20035482)
45. Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. Roussel AM, Kerkeni A, Zouari N, Mahjoub S, Matheau JM, Anderson RA, J Am Coll Nutr 2003 22 316 321 12897047 (Pubitemid 36927768)
46. Oral zinc supplementation does not improve oxidative stress or vascular function in patients with type 2 diabetes with normal zinc levels. Seet RCS, Lee CYJ, Lim ECH, Quek AML, Huang H, Huang SH, Looi WF, Long LH, Halliwell B, Atherosclerosis 2011 219 231 239 10.1016/j.atherosclerosis.2011.07.097 21840002
47. Insulinomimetic bis(maltolato)zinc(II) complex: blood glucose normalizing effect in KK-A(y) mice with type 2 diabetes mellitus. Yoshikawa Y, Ueda E, Miyake H, Sakurai H, Kojima Y, Biochem Biophys Res Commun 2001 281 1190 1193 10.1006/bbrc.2001.4456 11243860 (Pubitemid 32924544)
48. Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants. Haase H, Maret W, Biometals 2005 18 333 338 10.1007/s10534-005-3707-9 16158225 (Pubitemid 41298017)
49. Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes. Tang X, Shay NF, J Nutr 2001 131 1414 1420 11340092 (Pubitemid 32422959)
50. Zinc, a regulator of islet function and glucose homeostasis. Wijesekara N, Chimienti F, Wheeler MB, Diabetes Obes Metab 2009 11 Suppl 4 202 214 19817803
51. Think zinc: New roles for zinc in the control of insulin secretion. Rutter GA, Islets 2010 2 49 50 10.4161/isl.2.1.10259 21099294
52. Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Prospective UK, Lancet 1998 352 854 865 9742977
53. Effects of exenatide (exendin-4) on glycemic control over 30weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Kendall DM, Riddle MC, Rosenstock J, Zhuang D, Kim DD, Fineman MS, Baron AD, Diabetes Care 2005 28 1083 1091 10.2337/diacare.28.5.1083 15855571 (Pubitemid 40616617)
54. Effects of zinc on plasma lipoprotein cholesterol concentrations in humans: a meta-analysis of randomised controlled trials. Foster M, Petocz P, Samman S, Atherosclerosis 2010 210 344 352 10.1016/j.atherosclerosis.2009.11.038 20034629
55. The effect of zinc supplementation in humans on plasma lipids, antioxidant status and thrombogenesis. Hughes S, Samman S, J Am Coll Nutr 2006 25 285 291 16943449 (Pubitemid 44414695)
56. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Age-Related Eye Disease Study Research Group, Arch Ophthalmol 2001 119 1417 1436 11594942
57. Zinc supplement use and risk of prostate cancer. Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC, Giovannucci EL, J Natl Cancer Inst 2003 95 1004 1007 10.1093/jnci/95.13.1004 12837837 (Pubitemid 36896718)
58. Excessive intake of zinc impairs immune responses. Chandra RK, JAMA 1984 252 1443 1446 10.1001/jama.1984.03350110043027 6471270 (Pubitemid 14037009)
59. A physiological amount of zinc supplementation: effects on nutritional, lipid, and thymic status in an elderly population. Boukaiba N, Flament C, Acher S, Chappuis P, Piau A, Fusselier M, Dardenne M, Lemonnier D, Am J Clin Nutr 1993 57 566 572 8460613 (Pubitemid 23096730)
60. Serum lipid peroxidation and antioxidant enzyme levels in male and female diabetic patients. Mahboob M, Rahman MF, Grover P, Singapore Med J 2005 46 322 324 15968442 (Pubitemid 40992146)
61. The antioxidant properties of zinc. Powell SR, J Nutr 2000 130 1447S 1454S 10801958 (Pubitemid 30244144)
62. Antioxidant effect of zinc in humans. Prasad AS, Bao B, Beck FW, Kucuk O, Sarkar FH, Free Radic Biol Med 2004 37 1182 1190 10.1016/j.freeradbiomed.2004. 07.007 15451058 (Pubitemid 39296743)
63. The zinc sandwich and growth. Payne-Robinson HM, Golden MH, Golden BE, Simeon DT, Lancet 1991 337 925 926 1673011
64. Zinc supplementation for the prevention of type 2 diabetes mellitus. Beletate V, El Dib RP, Atallah AN, Cochrane Database Syst Rev 2007 30 D005525